Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum KODK Q1 2026 Earnings Reported EPS of 021 No Revenue Disclosure Stock Declines SID Q1 2026 Earnings A Significant EPS Miss Amidst Positive Market Reaction CETY Q4 2024 Earnings EPS Misses Amid Sparse Disclosure Stock Declines MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue SRAD Q1 2026 Earnings EPS Misses Estimates but Stock Rises 124 ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds YETI Q1 2026 Earnings Strong Profit Beat Drives Shares Higher SLDB Q1 2026 Earnings WiderthanExpected Loss Amid Pipeline Progress American Rebel Holdings Inc AREB Q1 2026 Earnings Stock Rises Despite Deep PerShare Loss